Grossman Adam S
Reporting owner on Forms 3, 4 and 5, CIK 1542517.
Grossman Adam S reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ADMA · ADMA BIOLOGICS, INC.CIK 1368514 | director, officer (President and CEO) | 2 | 2026-11-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ADMA · ADMA BIOLOGICS, INC.Common Stock | 2026-11-16 | M exercised | +15,000 | $5.4 | 2,085,777 | Form 4 |
| ADMA · ADMA BIOLOGICS, INC.Common Stock | 2026-11-16 | S sold | -15,000 | $13.72 | 2,070,777 | Form 4 |
| ADMA · ADMA BIOLOGICS, INC.Common Stock | 2026-11-16 | S sold | -6,000 | $13.72 | 2,064,777 | Form 4 |
| ADMA · ADMA BIOLOGICS, INC.Common Stock, holding | 1,143,426 | Form 4 | ||||
| ADMA · ADMA BIOLOGICS, INC.Common Stock, holding | 580,957 | Form 4 | ||||
| ADMA · ADMA BIOLOGICS, INC.Stock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -15,000 | $0 | 570,950 | Form 4 |
| ADMA · ADMA BIOLOGICS, INC.Common Stock | 2026-11-05 | M exercised | +105,000 | $5.4 | 2,217,777 | Form 4 |
| ADMA · ADMA BIOLOGICS, INC.Common Stock | 2026-11-05 | S sold | -105,000 | $12 | 2,112,777 | Form 4 |
| ADMA · ADMA BIOLOGICS, INC.Common Stock | 2026-11-05 | S sold | -42,000 | $12 | 2,070,777 | Form 4 |
| ADMA · ADMA BIOLOGICS, INC.Common Stock, holding | 1,143,426 | Form 4 | ||||
| ADMA · ADMA BIOLOGICS, INC.Common Stock, holding | 580,957 | Form 4 | ||||
| ADMA · ADMA BIOLOGICS, INC.Stock Option (Right to Buy), derivative | 2026-11-05 | M exercised | -105,000 | $0 | 585,950 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001140361-26-044291 | ADMA BIOLOGICS, INC. | 2026-11-16 | ||
| Form 4 0001140361-26-042166 | ADMA BIOLOGICS, INC. | 2026-11-05 |